Ryan Wiebe
Overview
Explore the profile of Ryan Wiebe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Majumder M, Tutunea-Fatan E, Xin X, Rodriguez-Torres M, Torres-Garcia J, Wiebe R, et al.
PLoS One
. 2012 May;
7(4):e35094.
PMID: 22545097
Introduction And Objectives: Lymphatic metastasis is a common occurrence in human breast cancer, mechanisms remaining poorly understood. MDA-MB-468LN (468LN), a variant of the MDA-MB-468GFP (468GFP) human breast cancer cell line,...
2.
Zhanel G, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban D, et al.
Drugs
. 2007 May;
67(7):1027-52.
PMID: 17488146
The carbapenems are beta-lactam antimicrobial agents with an exceptionally broad spectrum of activity. Older carbapenems, such as imipenem, were often susceptible to degradation by the enzyme dehydropeptidase-1 (DHP-1) located in...
3.
Schurek K, Wiebe R, Karlowsky J, Rubinstein E, Hoban D, Zhanel G
Expert Rev Anti Infect Ther
. 2007 Apr;
5(2):185-98.
PMID: 17402834
Faropenem medoxomil is a new orally administered penem antibiotic. Its chiral tetrahydrofuran substituent at position C2 is responsible for its improved chemical stability and reduced CNS effects, compared with imipenem....